Moody National Bank Trust Division’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$692K Buy
7,788
+486
+7% +$46K 0.06% 311
2026
Q2
$629K Buy
7,302
+56
+0.8% +$4.91K 0.05% 313
2026
Q1
$655K Sell
7,246
-109
-1% -$10K 0.06% 296
2025
Q4
$661K Sell
7,355
-4,131
-36% -$392K 0.06% 297
2025
Q3
$1.13M Buy
11,486
+1,059
+10% +$105K 0.1% 228
2025
Q2
$951K Buy
+10,427
New +$1.01M 0.09% 254
2023
Q4
– Sell
-2,006
Closed -$225K – 650
2023
Q3
$225K Buy
2,006
+32
+2% +$4.06K 0.01% 551
2023
Q2
$287K Hold
1,974
– – 0.02% 522
2023
Q1
$255K Buy
1,974
+22
+1% +$2.76K 0.02% 541
2022
Q4
$249K Sell
1,952
-646
-25% -$75K 0.02% 528
2022
Q3
$272K Sell
2,598
-114
-4% -$12.5K 0.03% 497
2022
Q2
$285K Buy
+2,712
New +$322K 0.03% 423
2019
Q2
– Sell
-41
Closed -$5K – 989
2019
Q1
$5K Sell
41
-124
-75% -$14.1K ﹤0.01% 975
2018
Q4
$17K Buy
+165
New +$18.6K ﹤0.01% 502

Other funds holding ZBH

Moody National Bank Trust Division's ZBH Position: Q3 2026 in Review

Moody National Bank Trust Division increased its Zimmer Biomet (ZBH) stake by 6.7% in Q3 2026, buying an estimated $46K and bringing the position to 7,788 shares worth $692K. The position accounts for 0.06% of the portfolio, ranked #311.

Moody National Bank Trust Division first reported a position in ZBH in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.13M in Q3 2025. 27 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Moody National Bank Trust Division held 7,788 shares of Zimmer Biomet worth $692K as of Q3 2026.
  • Moody National Bank Trust Division bought 486 Zimmer Biomet shares in Q3 2026, an estimated $46K.
  • Zimmer Biomet made up 0.06% of Moody National Bank Trust Division's portfolio in Q3 2026, its #311 holding.
  • Moody National Bank Trust Division first reported a position in Zimmer Biomet in Q4 2018 and has held it in 14 quarters since.
  • Moody National Bank Trust Division's Zimmer Biomet position peaked at $1.13M in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Moody National Bank Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.